Skip to content
← Full study record

NCT03228537 · BASELINE

Baseline characteristics

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma · Source last updated 2026-08-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      28
    units
    Participants
groups
  1. description
    NEOADJUVANT: Patients receive atezolizumab IV over 30-60 minutes, pemetrexed disodium IV over 10 minutes, and cisplatin IV over 2 hours on day 1. Cycles repeats every 21 days for 4 cycles in the absence of disease progression or unexpected toxicity. SURGERY: Within 21-90 days after completion of neoadjuvant therapy, patients undergo extrapleural pneumonectomy (EPP) or pleurectomy/decortication (PD). Patients who undergo EPP will then undergo radiation therapy. MAINTENANCE: Within 90 days after completion of either PD or radiation (post-EPP), patients receive atezolizumab IV over 60 minutes on day 1. Treatment repeats every 21 days for up to 1 year in the absence of disease progression or unexpected toxicity.
    id
    BG000
    title
    Treatment (Chemotherapy, Surgery +/- RT, Maintenance)
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          31.5
          upper Limit
          77.3
          value
          68.1
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          8
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          20
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          27
        title
        No
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Unknown
      title
      Hispanic
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          24
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          3
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          1
        title
        Unknown
      title
      Race
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          4
        title
        Extrapleural Pneumonectomy (EPP)
      2. measurements
        1. group Id
          BG000
          value
          24
        title
        Pleurectomy/Decortication (PD)
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Surgery
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        title
        0
      2. measurements
        1. group Id
          BG000
          value
          13
        title
        1
    description
    Performance Status uses the Zubrod Scale as follows: 0 - Fully active, able to carry on all pre-disease performance w/o restriction 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Performance Status
    unit Of Measure
    Participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          23
        title
        <6%
      2. measurements
        1. group Id
          BG000
          value
          4
        title
        5-<10%
      3. measurements
        1. group Id
          BG000
          value
          1
        title
        Pending
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Weight Loss Past 6 Months
    unit Of Measure
    Participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          22
        title
        Measurable
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Not Assessable
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Baseline Disease Status mRECIST
    unit Of Measure
    Participants
  9. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        title
        Measurable
      2. measurements
        1. group Id
          BG000
          value
          14
        title
        Non-Measurable
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Baseline Disease Status RECIST
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      28
    units
    Participants
groups
  1. description
    NEOADJUVANT: Patients receive atezolizumab IV over 30-60 minutes, pemetrexed disodium IV over 10 minutes, and cisplatin IV over 2 hours on day 1. Cycles repeats every 21 days for 4 cycles in the absence of disease progression or unexpected toxicity. SURGERY: Within 21-90 days after completion of neoadjuvant therapy, patients undergo extrapleural pneumonectomy (EPP) or pleurectomy/decortication (PD). Patients who undergo EPP will then undergo radiation therapy. MAINTENANCE: Within 90 days after completion of either PD or radiation (post-EPP), patients receive atezolizumab IV over 60 minutes on day 1. Treatment repeats every 21 days for up to 1 year in the absence of disease progression or unexpected toxicity.
    id
    BG000
    title
    Treatment (Chemotherapy, Surgery +/- RT, Maintenance)
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          31.5
          upper Limit
          77.3
          value
          68.1
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          8
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          20
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          27
        title
        No
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Unknown
      title
      Hispanic
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          24
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          3
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          1
        title
        Unknown
      title
      Race
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          4
        title
        Extrapleural Pneumonectomy (EPP)
      2. measurements
        1. group Id
          BG000
          value
          24
        title
        Pleurectomy/Decortication (PD)
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Surgery
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        title
        0
      2. measurements
        1. group Id
          BG000
          value
          13
        title
        1
    description
    Performance Status uses the Zubrod Scale as follows: 0 - Fully active, able to carry on all pre-disease performance w/o restriction 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Performance Status
    unit Of Measure
    Participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          23
        title
        <6%
      2. measurements
        1. group Id
          BG000
          value
          4
        title
        5-<10%
      3. measurements
        1. group Id
          BG000
          value
          1
        title
        Pending
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Weight Loss Past 6 Months
    unit Of Measure
    Participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          22
        title
        Measurable
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Not Assessable
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Baseline Disease Status mRECIST
    unit Of Measure
    Participants
  9. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        title
        Measurable
      2. measurements
        1. group Id
          BG000
          value
          14
        title
        Non-Measurable
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Baseline Disease Status RECIST
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice